tiprankstipranks
Upstream Bio, Inc. (UPB)
NASDAQ:UPB
US Market
UPB
Upstream Bio, Inc.
RESEARCH TOOLSreports

Upstream Bio, Inc. (UPB) Stock Forecast & Price Target

Compare
257 Followers
See the Price Targets and Ratings of:

UPB Analyst Ratings

Strong Buy
7Ratings
Strong Buy
7 Buy
0 Hold
0 Sell
Based on 7 analysts giving stock ratings to
Upstream
Bio, Inc.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

UPB Stock 12 Month Forecast

Average Price Target

$52.67
▲(73.82% Upside)
Based on 7 Wall Street analysts offering 12 month price targets for Upstream Bio, Inc. in the last 3 months. The average price target is $52.67 with a high forecast of $75.00 and a low forecast of $40.00. The average price target represents a 73.82% change from the last price of $30.30.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"5":"$5","76":"$76","22.75":"$22.8","40.5":"$40.5","58.25":"$58.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$75.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":52.66666666666667,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$52.67</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":40,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$40.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[5,22.75,40.5,58.25,76],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.7,12.876923076923077,18.053846153846152,23.23076923076923,28.407692307692304,33.58461538461538,38.76153846153846,43.93846153846154,49.11538461538461,54.29230769230769,59.46923076923076,64.64615384615384,69.82307692307691,{"y":75,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.7,11.158974358974358,14.617948717948718,18.076923076923077,21.535897435897436,24.994871794871795,28.453846153846154,31.912820512820513,35.371794871794876,38.830769230769235,42.289743589743594,45.74871794871795,49.20769230769231,{"y":52.66666666666667,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.7,10.184615384615384,12.669230769230769,15.153846153846153,17.638461538461538,20.123076923076923,22.607692307692304,25.09230769230769,27.576923076923073,30.061538461538458,32.54615384615384,35.03076923076923,37.51538461538461,{"y":40,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":7.93,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.7,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.66,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.79,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.54,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.26,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.63,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.85,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.98,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.15,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.94,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.7,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$75.00Average Price Target$52.67Lowest Price Target$40.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen Analyst forecast on UPB
Yaron Werber
TD Cowen
TD Cowen
―
Buy
―
Reiterated
03/11/26
Analysts Offer Insights on Healthcare Companies: Upstream Bio, Inc. (NASDAQ: UPB), TScan Therapeutics (NASDAQ: TCRX) and Teladoc (NYSE: TDOC)
LifeSci Capital Analyst forecast on UPB
Kate Dellorusso
LifeSci Capital
LifeSci Capital
$43
Buy
41.91%
Upside
Reiterated
03/03/26
Analysts Are Bullish on These Healthcare Stocks: Upstream Bio, Inc. (UPB), Passage Bio (PASG)
J.P. Morgan Analyst forecast on UPB
Tessa Romero
J.P. Morgan
J.P. Morgan
―
Buy
―
Reiterated
03/02/26
Buy Rating on UPB Driven by Robust Verekitug Phase 2 Data and Upcoming Phase 3 Catalysts in CRSwNP and Severe Asthma
William Blair Analyst forecast on UPB
Matt Phipps
William Blair
William Blair
―
Buy
―
Reiterated
03/02/26
Analysts Offer Insights on Healthcare Companies: Aardvark Therapeutics, Inc. (NASDAQ: AARD), Upstream Bio, Inc. (NASDAQ: UPB) and Cogent Biosciences (NASDAQ: COGT)
Evercore ISI Analyst forecast on UPB
Cory Kasimov
Evercore ISI
Evercore ISI
$40
Buy
32.01%
Upside
Reiterated
02/12/26
Evercore ISI Remains a Buy on Upstream Bio, Inc. (UPB)
Truist Financial Analyst forecast on UPB
Danielle Brill
Truist Financial
Truist Financial
―
Buy
―
Reiterated
02/12/26
Analysts Offer Insights on Healthcare Companies: Nuvectis Pharma (NASDAQ: NVCT), Tenet Healthcare (NYSE: THC) and Upstream Bio, Inc. (NASDAQ: UPB)
Piper Sandler Analyst forecast on UPB
Yasmeen Rahimi
Piper Sandler
Piper Sandler
$75
Buy
147.52%
Upside
Reiterated
01/26/26
Piper Sandler Remains a Buy on Upstream Bio, Inc. (UPB)
Mizuho Securities Analyst forecast on UPB
Joseph Catanzaro
Mizuho Securities
Mizuho Securities
$51
Buy
68.32%
Upside
Initiated
12/18/25
Upstream Bio initiated with an Outperform at MizuhoUpstream Bio initiated with an Outperform at Mizuho
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen Analyst forecast on UPB
Yaron Werber
TD Cowen
TD Cowen
―
Buy
―
Reiterated
03/11/26
Analysts Offer Insights on Healthcare Companies: Upstream Bio, Inc. (NASDAQ: UPB), TScan Therapeutics (NASDAQ: TCRX) and Teladoc (NYSE: TDOC)
LifeSci Capital Analyst forecast on UPB
Kate Dellorusso
LifeSci Capital
LifeSci Capital
$43
Buy
41.91%
Upside
Reiterated
03/03/26
Analysts Are Bullish on These Healthcare Stocks: Upstream Bio, Inc. (UPB), Passage Bio (PASG)
J.P. Morgan Analyst forecast on UPB
Tessa Romero
J.P. Morgan
J.P. Morgan
―
Buy
―
Reiterated
03/02/26
Buy Rating on UPB Driven by Robust Verekitug Phase 2 Data and Upcoming Phase 3 Catalysts in CRSwNP and Severe Asthma
William Blair Analyst forecast on UPB
Matt Phipps
William Blair
William Blair
―
Buy
―
Reiterated
03/02/26
Analysts Offer Insights on Healthcare Companies: Aardvark Therapeutics, Inc. (NASDAQ: AARD), Upstream Bio, Inc. (NASDAQ: UPB) and Cogent Biosciences (NASDAQ: COGT)
Evercore ISI Analyst forecast on UPB
Cory Kasimov
Evercore ISI
Evercore ISI
$40
Buy
32.01%
Upside
Reiterated
02/12/26
Evercore ISI Remains a Buy on Upstream Bio, Inc. (UPB)
Truist Financial Analyst forecast on UPB
Danielle Brill
Truist Financial
Truist Financial
―
Buy
―
Reiterated
02/12/26
Analysts Offer Insights on Healthcare Companies: Nuvectis Pharma (NASDAQ: NVCT), Tenet Healthcare (NYSE: THC) and Upstream Bio, Inc. (NASDAQ: UPB)
Piper Sandler Analyst forecast on UPB
Yasmeen Rahimi
Piper Sandler
Piper Sandler
$75
Buy
147.52%
Upside
Reiterated
01/26/26
Piper Sandler Remains a Buy on Upstream Bio, Inc. (UPB)
Mizuho Securities Analyst forecast on UPB
Joseph Catanzaro
Mizuho Securities
Mizuho Securities
$51
Buy
68.32%
Upside
Initiated
12/18/25
Upstream Bio initiated with an Outperform at MizuhoUpstream Bio initiated with an Outperform at Mizuho
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Upstream Bio, Inc.

3 Months
xxx
Success Rate
6/8 ratings generated profit
75%
Average Return
+20.40%
reiterated a xxx
 rating 15 days ago
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +20.40% per trade.
1 Year
Yaron WerberTD Cowen
Success Rate
3/8 ratings generated profit
38%
Average Return
-19.63%
reiterated a buy rating 15 days ago
Copying Yaron Werber's trades and holding each position for 1 Year would result in 37.50% of your transactions generating a profit, with an average return of -19.63% per trade.
2 Years
xxx
Success Rate
2/8 ratings generated profit
25%
Average Return
-24.84%
reiterated a xxx
 rating 15 days ago
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 25.00% of your transactions generating a profit, with an average return of -24.84% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

UPB Analyst Recommendation Trends

Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
3
6
6
7
5
Buy
9
6
10
10
12
Hold
21
22
14
7
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
33
34
30
24
18
In the current month, UPB has received 17 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. UPB average Analyst price target in the past 3 months is 52.67.
Each month's total comprises the sum of three months' worth of ratings.

UPB Financial Forecast

UPB Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.

UPB Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

UPB Stock Forecast FAQ

What is UPB’s average 12-month price target, according to analysts?
Based on analyst ratings, Upstream Bio, Inc.’s 12-month average price target is 52.67.
    What is UPB’s upside potential, based on the analysts’ average price target?
    Upstream Bio, Inc. has 73.82% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is UPB a Buy, Sell or Hold?
          Upstream Bio, Inc. has a consensus rating of Strong Buy which is based on 7 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Upstream Bio, Inc.’s price target?
            The average price target for Upstream Bio, Inc. is 52.67. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $75.00 ,the lowest forecast is $40.00. The average price target represents 73.82% Increase from the current price of $30.3.
              What do analysts say about Upstream Bio, Inc.?
              Upstream Bio, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
                How can I buy shares of UPB?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.